This section of the website is for UK Healthcare Professionals only. 
If you are not a Healthcare Professional, please click here.

The Pharmacist’s Role in Optimising PBC Care and Improving Clinical Practice

Primary Biliary Cholangitis (PBC) Video
60:00

This on‑demand webinar explores the evolving role of pharmacists in optimising care for people living with primary biliary cholangitis (PBC). Featuring expert pharmacists, the session covers the PBC clinical landscape, national guidance, symptom burden and treatment optimisation, alongside practical use of the PBC Care Bundle. It also highlights how pharmacists can optimise their role through MDT working, pharmacist‑led clinics and service innovation to improve patient outcomes and quality of life.

Featuring:
Yun Kim (Chair): Consultant-level Hepatology Pharmacist, University Hospital Southampton NHS Foundation Trust
Fiona Rees: Consultant Pharmacist in AIH, PBC, Viral Hepatitis and IBD, University Hospitals Sussex – Brighton
Robert Elliot-Cooke: Lead Hepatology & Hepatitis C ODN Pharmacist, Chief Pharmacy Information Officer, University Hospitals Plymouth NHS Trust
Fatema Jessa: Consultant Pharmacist for Hepatology and Liver Transplant at the Royal Free London NHS Foundation Trust

IQV-UK-000964 | April 2026

Explore more Primary Biliary Cholangitis (PBC) Events & Meetings

Explore more Primary Biliary Cholangitis (PBC) Events & Meetings

Browse

To access relevant information about Primary Biliary Cholangitis, please confirm the following:

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Side effects should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone 01753 627777. By reporting side effects, you can help provide more information on the safety of this medicine.